CD274 and cancer: However, although PD1-PD-L1 interaction blockade has been generally successful in clinical trials for melanoma, NSCLC, renal cell cancer and ovarian cancer, the same treatments have not provided objective responses in other cancers including pancreat-ic cancer patients [14].